Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis.
D Y Leung, … , M Lareau, R S Geha
D Y Leung, … , M Lareau, R S Geha
Published October 1, 1983
Citation Information: J Clin Invest. 1983;72(4):1482-1486. https://doi.org/10.1172/JCI111104.
View: Text | PDF
Research Article

Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis.

  • Text
  • PDF
Abstract

The T cell proliferative response to autologous non-T cells is termed the autologous mixed lymphocyte reaction (AMLR). Recent studies have suggested that the AMLR represents an inducer circuit for the activation of T8+ suppressor/cytotoxic effector cells. Since atopic dermatitis (AD) patients are deficient in T8+ cytolytic T cell function, we investigated the AMLR in AD. When sheep erythrocytes were used to separate T cells from non-T cells, the AMLR was found to be significantly decreased (P less than 0.001) in AD patients (n = 11; delta cpm = 1,550 +/- 393) when compared with normal control subjects (n = 13; delta cpm = 25,819 +/- 4,609). To exclude the possibility that these results were an artifact of the sheep erythrocyte separation, T cells were also separated on a fluorescence-activated cell sorter after treatment of peripheral blood lymphocytes with the OKT3 monoclonal antibody. AD T cells separated by the latter method were also found to have a significantly reduced AMLR response when compared with similarly treated normal T cells. Co-culture studies using cells from AD patients and their HLA identical siblings indicated that the defect resided at the responder T cell level rather than at the stimulator non-T cell level. Co-culture studies revealed no evidence for excessive suppressor cell activity resulting in the decreased AMLR. However, enumeration of T cells reactive with the monoclonal antibody T29, which recognizes a subset of T cells proliferating in the AMLR, demonstrated that AD patients (n = 8; % T29 = 2.5 +/- 0.7) had a significantly decreased (P less than 0.001) number of circulating T29+ T cells when compared with normal controls (n = 8; % T29 = 10.4 +/- 0.8). These studies suggest that a deficiency of T4+ T29+ cells contributes to the deficient AMLR in AD and possibly underlies the abnormalities of T8+ effector cells present in this disease.

Authors

D Y Leung, J A Saryan, R Frankel, M Lareau, R S Geha

×

Total citations by year

Year: 2006 2003 2001 1992 1991 1990 1989 1987 1986 1984 Total
Citations: 1 1 1 2 1 2 2 2 4 2 18
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (18)

Title and authors Publication Year
Handbook of Atopic Eczema
J Ring, B Przybilla, T Ruzicka
2006
The defect of the perforin granule system in cytotoxic T lymphocytes of atopic patients - are perforin reduction and hyperreleasability of clinical relevance?. Zum Defekt des Perforin-Granulasystems zytotoxischer T-Lymphozyten bei Patienten mit Atopie - Sind Perforin-Reduktion und -Hyperreleasability klinisch relevant?
A Ambach, B Bonnekoh, H Gollnick
Journal der Deutschen Dermatologischen Gesellschaft 2003
Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica
A Ambach, B Bonnekoh, H Gollnick
Journal of Allergy and Clinical Immunology 2001
Altered spontaneous and histamine-induced in vitro suppressor-cell function in dogs with atopic dermatitis
JS Wilkie, BN Wilkie, JA Yager, P Eyre
Veterinary Immunology and Immunopathology 1992
Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations
KH Hsieh, MF Shaio, TN Liao
Archives of disease in childhood 1992
Interleukin 2 therapy in severe atopic dermatitis
KH Hsieh, CC Chou, SF Huang
Journal of Clinical Immunology 1991
Autologous mixed lymphocyte reaction is reduced in patients with psoriasis
T Terui, M Rokugo, S Aiba, T Kato, H Tagami
British Journal of Dermatology 1990
Immunologic Aspects of Atopic Dermatitis
JM Hanifin
Dermatologic Clinics 1990
Antihistamines in atopic dermatitis
G Ciprandi, A Scordamaglia, S Buscaglia, G Passalacqua, GW Canonica
Allergy 1989
Pharmacology of the Skin I
MW Greaves, S Shuster
1989
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin
DY Leung, JC Burns, JW Newburger, RS Geha
Journal of Clinical Investigation 1987
Langerhans Cell-- and T-Lymphocyte Functions in Patients With Atopic Dermatitis With Disseminated Cutaneous Herpes Simplex Virus Infection
L Rasanen, M Lehto, T Reunala, C Jansen, M Lehtinen, P Leinikki
Journal of Investigative Dermatology 1987
Cellular abnormalities in patients with elevated serum IgE levels
RS Geha, DY Leung
Journal of Allergy and Clinical Immunology 1986
Proliferative Response in Solid Culture of t Cells From Patients with Extrinsic Bronchial Asthma
J Carvajal, A Rivas, DP Ponce, NE Bianco
Immunological Investigations 1986
Cell-mediated immunity in cutaneous disease
SM Breathnach, SI Katz
Human Pathology 1986
Immunoregulatory abnormalities in atopic dermatitis
D Y Leung, R S Geha
Clinical Reviews in Allergy 1986
Eczematous and immunologic diseases
I Gigli, JM Hanifin, SI Katz, TT Provost, NA Soter
Journal of the American Academy of Dermatology 1984
Human Immunoregulation an Overview
JL Ceuppens
ACTA CLINICA BELGICA 1984

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts